clinical practice

Enabling Early Detection and Intervention for Cerebral Palsy

2024-04-09T09:51:21-08:00

Challenge Doctors should ideally diagnose cerebral palsy (CP) before a baby’s first birthday, according to international guidelines. This way, the child can access early interventions that will help them reach their fullest potential for movement and function. However, the average age for a CP diagnosis in Canada is 18.9 months, and treatment doesn’t always [...]

Finding a Way to Diagnosis Cerebral Palsy Sooner

2023-10-19T10:23:57-08:00

Challenge When it comes to neurodevelopmental disabilities, early diagnosis is critical so that children can access supports and interventions early on. For cerebral palsy (CP), it is generally recommended that children be diagnosed as early as possible. Using new tools, in many cases this is potentially feasible by primary care physicians before infants with CP [...]

The Neuroethics Core: Action- and Solution-Oriented Best Practices

2023-05-04T06:41:08-08:00

Challenge Persons in research institutions, hospitals and governments make decisions every day that affect the well-being of children with neurodevelopmental disabilities (NDDs). The KBHN Neuroethics Core sought to find ways to help doctors, scientists, policymakers and parents with their ethical decision-making. Project Summary and The neuroethics core at Kids Brain Health Network helped people navigate [...]

Quantitative modelling of spontaneous movement in infants

2023-10-19T10:45:42-08:00

Challenge In young babies, assessment of their motions has been used to predict complex neurological dysfunction later in life. Infant movement has been identified as the 7th cardinal sign of neurological dysfunction. However, this method is limited, partially due to the skills that are required to deliver a clear qualitative assessment of a baby's motion. [...]

The ASD Demonstration Project: Translation of Genomic Discoveries into Clinical Practice

2023-10-19T10:52:46-08:00

Challenge A person’s genome could contain useful information about their risk of autism spectrum disorder, but how should genome sequencing be used in diagnosis, genetic counselling and patient management? What treatments and follow-ups should come after what kinds of test results? And how should these very complex and sometimes ambiguous results be conveyed? How can [...]

Go to Top